RENOVACOR, INC.

Profile

Company Names

RENOVACOR, INC.

Addresses

5 MEAD POINT DRIVE, GREENWHICH, CT 06830

Phone Numbers

203-524-0788

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$6,300,033.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-07-20 
$2,500,000.00 
$2,500,000.00 
$0.00 
Debt 
1
2019-08-12 
$3,800,033.00 
$11,050,004.00 
$7,249,971.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EDWARD 
J 
BENZ 
DIRECTOR
RENOVACOR, INC.
EDWARD 
J. 
BENZ, JR. 
DIRECTOR
DECIPHERA PHARMACEUTICALS, LLC   |  RENOVACOR, INC.   |  COREGEN, INC.
MAGDALENE 
 
COOK 
EXECUTIVE OFFICER, DIRECTOR
LABNOW INC   |  RENOVACOR, INC.
WENDY 
 
DICICCO 
EXECUTIVE OFFICER
QUENCH USA, INC.   |  CANNAPHARMARX, INC.   |  CENTINEL SPINE, LLC   |  CARMELL THERAPEUTICS CORP   |  RENOVACOR, INC.   |  IMVAX, INC.   |  EYEPOINT PHARMACEUTICALS, INC.   |  EXPRESSCELLS, INC.   |  AKARI THERAPEUTICS PLC
ARTHUR 
 
FELDMAN 
DIRECTOR
RENOVACOR, INC.
CAMPBELL 
 
MURRAY 
DIRECTOR
ALIOS BIOPHARMA INC   |  TOKAI PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  BIORELIX INC   |  EUTHYMICS BIOSCIENCE INC   |  AKEBIA THERAPEUTICS, INC.   |  AERPIO THERAPEUTICS, INC.   |  NEUROVANCE, INC.   |  EBI LIFE SCIENCES, INC.   |  IMAGINAB, INC.   |  GALERA THERAPEUTICS, INC.   |  BIONANO GENOMICS, INC   |  EUTHYMICS BIOSCIENCE, INC.   |  ICEBREAKER HEALTH, INC.   |  ANNEXON, INC.   |  TSCAN THERAPEUTICS, INC.   |  RENOVACOR, INC.   |  LIGHTHOUSE PHARMACEUTICALS, INC.
THOMAS 
 
NEEDHAM 
DIRECTOR
PREXA PHARMACEUTICALS INC   |  TRIDENT PHARMACEUTICALS INC   |  RENOVACOR, INC.   |  BASKING BIOSCIENCES, INC.   |  KANTUM PHARMA, INC.
MARC 
 
SEMIGRAM 
EXECUTIVE OFFICER
RENOVACOR, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-08-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-07-20 
2019-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#